Live: https://onco.cc

OnCo — это открытый репозиторий для рака. Весь корпус — каждая страница, источник, чертеж, перевод и скрипт — находится в этом репозитории под открытой лицензией (CC BY-NC 4.0 для данных, MIT для кода), встроенной публично, исправленной через проблемы и pull requests, а также бесплатной для пациентов, клиницистов, исследователей, компаний и агентов ИИ, чтобы они могли читать и использовать повторно. Если вы знаете что-то, чего нет на сайте, откройте проблему или pull request: gate выполняет одинаковые проверки каждого вклада.

OnCo — это публичный, цитируемый граф знаний по онкологии, направленный на полное информационное доминирование по раку: каждый рак, фронт, технология, цель, показание биомаркеров, лечение и тестирование, компания, учреждение, человек, путь, исследование, ключевая статья, журнал, сочетание, дорожная карта, узкое место и идея, по одной странице каждая, с простым английским TL; DR перед техническим слоем и ссылками во всех направлениях. Читатели начинают с глобального взгляда и выбирают свою страну, так что «одобрено» означает вердикт их регулятора.

OnCo: Total information dominance on cancer.

Live: https://onco.cc

OnCo is an open repository for cancer. The whole corpus, every page, source, drawing, translation and script, is in this repository under an open licence (CC BY-NC 4.0 for the data, MIT for the code), built in public, corrected through issues and pull requests, and free for patients, clinicians, researchers, companies and AI agents to read and reuse. If you know something the site does not, open an issue or a pull request: the gate runs the same checks on every contribution.

OnCo is a public, cited knowledge graph of oncology, aiming at total information dominance on cancer: every cancer, front, technology, target, biomarker readout, treatment and test, company, institution, person, pathway, trial, key paper, journal, pairing, roadmap, bottleneck and idea, one page each, with a plain-English TL;DR before the technical layer and links in every direction. Readers start in a Global view and pick their country, so “approved” means their regulator’s verdict. It exists so that a patient, a carer, a clinician, a scientist, an investor or a policymaker can walk from any object to everything connected to it and see the state of the art, the history, what is being done about each problem, and what is coming.

The website is one surface. The same corpus ships as:

• the site (https://onco.cc): tables with filters, tooltips on every technical term, molecule and target renderings, animated schematics, a graph explorer, Ask OnCo question answering, a living-with-cancer area (side effects, symptoms, second opinions, hair loss, complementary approaches graded by evidence), coverage of what insurers and the NHS pay for, and a completeness dashboard that states how much of the known world each kind covers;
• a static JSON API under https://onco.cc/api/v1/ with CORS, per-entity Markdown context files for language models, Atom feeds and RDF triples;
• an MCP server and a command-line tool (packages/), so agents and scripts can search, fetch, compare and ask over the corpus;
• browser WebMCP tools for read-only record search and lookup in supporting browsers (implementation and testing);
• eight interface languages with translated TL;DRs where a translation exists.

Work in progress. Verify at source. Every fact is being built and checked in the open and may be incomplete, out of date or wrong. Nothing here is medical advice. Do your own research and check anything that matters at its primary source, which every page links.

Current counts live at https://onco.cc/about/ and print from npm run validate. This file deliberately carries no numbers, so it never goes stale.

Screenshots

Captured from the built site on 17 September 2026. Click any image to open the live page.